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a b s t r a c t
We have analyzed the receptor binding proﬁle of A(H1N1)pdm09 recombinant inﬂuenza viruses
containing the amino acid substitution D222N which has been associated with a fatal case of infection.
This mutation was investigated in conjunction with a secondary mutation, S185N. Using human
tracheobronchial epithelial cells (HTBE), we found that single mutation D222N affects the binding and
replication of the virus during initial stages of infection, with limited but preferred tropism to non-
ciliated cells expressing α2,6-SA. However, in conjunction with the S185N change, the (D222N, S185N)
virus shows a remarkable increase in binding and replication efﬁciency, with tropism for both ciliated
and non-ciliated cells. Glycan microarray analysis demonstrated correlation between the binding proﬁle
and the cell tropism observed in the HTBE cells. These ﬁndings suggest that viruses with D222N required
compensatory mutations such as S185N to maintain viral ﬁtness, and in combination, affect the
pathogenicity of the virus and the clinical outcome.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The 2009 inﬂuenza pandemic in Mexico was characterized by an
unusual increase in the number of severe and fatal respiratory
infections associated with the isolation of the novel inﬂuenza A
(H1N1)pdm09 virus (Chowell et al., 2009). The inﬂuenza outbreak
in southern Mexico between June and August of that year was
considered the second wave of the pandemic, with the highest
number of infections reported in Yucatan (Chowell et al., 2011).
During this time and in the following months, the health authorities
in Yucatan recorded a total of 92 cases of severe or fatal inﬂuenza
infection (Ayora-Talavera et al., 2012). Molecular markers of patho-
genicity, including amino acid changes mapping to the receptor
binding site (RBS) of the viral hemagglutinin (HA) were found in
some of the patients with severe or fatal inﬂuenza infections. Isolates
of the new A(H1N1)pdm09 virus containing a D222G amino acid
change in the RBS were reported in different geographic regions at
frequencies varying from 5% up to 24% (Chen et al., 2010; El Moussi
et al., 2013; Ledesma et al., 2011; Rykkvin et al., 2013; Vazquez-Perez
et al., 2013). The pathogenic effects of viruses with the D222G
mutation have been analyzed in mice, Guinea pigs, and ferrets, but
the results and conclusions differ depending on the study and animal
model utilized (Abed et al., 2011; Casalegno et al., 2014; Chutinimitkul
et al., 2010; Vazquez-Perez et al., 2013).
The genetic polymorphism 222D/G/N in HA amino acid 222 of the
A(H1N1)pdm09 virus has been identiﬁed in circulating viruses, and
for virus populations within the same host a higher frequency of
mutants with G, N, or both, is suggested to relate to the severity of the
infection (Baldanti et al., 2011; Resende et al., 2014). Interestingly, the
D222N mutation has generally been detected in combination with D
or G heterogeneity at this position, and in only few reports as the
major population (Baldanti et al., 2011; Casalegno et al., 2014; Drews
et al., 2011; Resende et al., 2014; Wang et al., 2011). The presence of
any polymorphism at residue 222 may confer changes to the virus
receptor binding proﬁle and the cell/tissue tropism, as D222G HA
mutants of A(H1N1)pdm09 virus showed a preference for infection of
ciliated cells from HTBE (Chutinimitkul et al., 2010), consistent with
α2,3-SA speciﬁcity (Matrosovich et al., 2004; Thompson et al., 2006),
and with changes in the tissue tropism as demonstrated for the highly
pathogenic H5N1 virus (Shinya et al., 2006; Van Riel, et al., 2006).
However, the A(H1N1)pdm09 virus with D222G also retained ability
to infect non-ciliated cells expressing α2,6-SA, showing dual receptor
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speciﬁcity, as well as dual binding to α2,3-SA and α2,6-SA glycans
(Chutinimitkul et al., 2010; Liu et al., 2010; Yang et al., 2010).
A(H1N1)pdm09 viruses with the HA D222N substitution have
also been isolated and characterized since 2009 (Wang et al.,
2011), and viruses with this mutation have been detected during
outbreaks of severe and fatal inﬂuenza in Mexico, Ecuador, and the
U.S. Interestingly, these cases were associated with a prominent
D222N and not the polymorphic trait of past isolates. Phylogenetic
analysis identiﬁed a new sub-clade containing additional amino
acid changes within the HA: N31D, S162N, A186T and V272I
(Houng et al., 2012). The role of these mutations on the biology
of the pandemic virus is unknown.
Although the glycan binding proﬁles of both natural and
recombinant A(H1N1)pdm09 viruses containing the mutation
D222N have been reported (Bradley et al., 2011; Chen et al.,
2011), the precise role of the amino acid change D222N on the
severity of the infection is unclear. In this study, we address
further the receptor binding phenotype of A(H1N1)pdm09 viruses
with polymorphisms 222D/N, and the effect on the cell tropism
using the in vitro system of human airway epithelial cells.
Results and discussion
Mutation D222N affects the early replication of A(H1N1)pdm09 virus
in HTBE cultures but is compensated by secondary mutations in the
antigenic site Sb
In order to identify mutations in the HA RBS that might affect
binding phenotype and pathogenicity, we performed sequence
analysis of HA genes from 13 viral isolates from severe and fatal
cases from Yucatan, Mexico. From this, relevant mutations were
identiﬁed in only two viruses, A/Yucatan/5783/2009 (Yuc/5783)
and A/Yucatan/3882/2009 (Yuc/3882). The Yuc/5783 virus was
isolated from the bronchial lavage of a hospital patient with a
severe case of Inﬂuenza. This virus contained a single mutation,
D190Y, at the HA protein. The effect of this mutation on the
receptor binding properties of the virus was recently described by
our group (Ayora-Talavera et al., 2014). The virus Yuc/3882,
isolated by throat swab from patient that subsequently died from
the infection, contained two mutations in the receptor binding
region of HA, S185N and D222N. Due to the relevance of the
mutation D222N and the lack of data about its speciﬁc role on the
pathogenicity of the pandemic virus, we examined the receptor
binding proﬁle and replication properties of viruses containing
this mutation. We also addressed the relevance of the mutation
S185N, located at the antigenic site Sb (Xu et al., 2010). A different
amino acid change, S185T, is reported to be conserved in all A
(H1N1)pdm09 viruses in current circulation, and its role in the
enhancement of receptor-binding avidity of the early A(H1N1)
pdm09 virus has been addressed (de Vries et al., 2013; ECDC 2013;
Elderﬁeld et al., 2014; Klimov et al., 2012).
Therefore we generated a series of mutants based on the
United Kingdom prototype A(H1N1)pdm09 virus, A/England/195/
2009 (Eng/195), altered only in the HA gene (Baillie et al., 2012).
Each mutant virus contained either amino acid substitution S185N
(rEng/195-S185N), D222N (rEng/195-D222N) or S185NþD222N
(rEng/195-S185NþD222N). Sequence analysis and comparison
between the Eng/195 and Yuc/3882 viruses indicated a 99.7%
homology for the HA protein with only three amino acid differ-
ences S185N, S203T and D222N.
The growth properties of the recombinant mutant viruses were
compared to recombinant Eng/195 (rEng/195-wt) in differentiated
pseudostratiﬁed human tracheal–bronchial epithelial cells (HTBE,
MatTek – Massachusetts, USA). Mutants with S185N whether as a
single mutant, or in combination with D225N (rEng/195-S185N
and rEng/195-S185NþD222N), replicated to higher titers at early
time points than did the wild type virus rEng/195-wt (Fig. 1A). At
12 h post-infection (h.p.i.) the two mutants with S185N already
displayed recoverable virus, whereas rEng/195-wt virus did not,
and at 24 h, the higher titers for the two mutants were signiﬁcant
(po0.0001). The slow replication of the rEng/195-wt virus is
probably due to differences in adaptation to the HTBE system;
our data are in agreement with recent results that showed a
delayed viral growth for the rEng/195-wt used as prototype virus
from the ﬁrst pandemic wave compared to a recombinant virus
from the third wave (Baillie et al., 2012; de Vries et al., 2013;
Elderﬁeld et al., 2014). Similar to the wt, the rEng/195-D222N
showed null viral growth at 12 h.p.i. (po0.0001), although at 24 h.
p.i. and at later timepoints, the virus reached a maximum viral
titer similar to the other two mutants. Overall, these results
suggest that the presence of mutation D222N alone has a negative
effect on the viral replication during the initial rounds of replica-
tion. However, the presence of mutation S185N alone, or in
combination with D222N, correlated with faster replication of
these viruses in HTBE cells at early time points.
In MDCK cells the growth curve (Fig. 1B) showed that rEng/195-
wt virus replicated most efﬁciently. Signiﬁcant differences were
observed between the rEng/195-wt viral titer versus rEng/195-
S185N at 12 (po0.01), and rEng/195-222N and rEng/195-
S188NþD222N (po0.0001) at 24 h post-infection. The rEng/
195-S185N virus displayed higher titers at 24 h than the other
two mutants. These data suggest that in MDCK cells, recombinant
viruses did not show replication constraints, even in the presence
of speciﬁc mutations. The delayed viral replication we previously
observed for the rEng/195-wt it was likely to be associated with
the complex HTBE culture system, a feature that allows the rEng/
195-D222N virus to replicate efﬁciently after 24 h post-infection.
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Fig. 1. Replication of viruses in cell culture. Growth kinetics of WT and mutated
viruses in (A) HTBE and (B) MDCK cultures. Cells were infected at an MOI of 0.001
or 0.01. Data represent the average7SD of three different experiments. Statistics
were calculated with the ANOVA test for repeated measures using GraphPad Prism
v5.0. Signiﬁcant differences were considered ****po0.0001; **po0.001.
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Notably, in the MDCK cells, recombinant viruses containing the
D222N polymorphism (rEng/195-D222N and rEng/195-S188Nþ
D222N) showed a reduction in viral replication, and we speculate
that this likely reﬂects differences in cell surface receptor compo-
sition compared to the HTBE cell.
Receptor binding proﬁle of A(H1N1)pdm09 virus with D222N and
secondary mutations at the Sb antigenic site
To identify potential differences in receptor recognition among
the viruses, we analyzed their binding properties using a carbohy-
drate microarray. Overall, the three mutant viruses displayed fairly
similar binding properties compared to the wild type virus
(Fig. 2A–D). All recombinant viruses showed signiﬁcant binding
to the α2,6 glycan #481 with a bifurcated structure, and binding
peaks were also observed to the glycan #331 with a linear
structure, though only for the rEng/195-wt and single mutant
rEng/195-S185N (Fig. 3A–D) was this considered signiﬁcant (two
times the background average, with a % CV of less than 50%). A
similar result was observed for the glycan #11 (Fig. 2A, C and D)
that consists in a single molecule of SA (Neu5Ac), with signiﬁcant
binding for the rEng/195-wt, rEng/195-D222N and the double
mutant rEng/195-S185NþD222N. Differences in sialic acid linkage
speciﬁcity of mutant viruses were also observed. The rEng/195-wt
virus bound signiﬁcantly to a wide number of α2,6 glycans but also
to a signiﬁcant number of α2,3 in agreement to previous reports
(Bradley et al., 2011; Chen et al., 2011). The rEng/195-D222N
bound signiﬁcantly to α2,6 glycans (#331, 481, 601 and 605) but
also bound to the α2,3-linked glycan #236. The weak binding to
α2,3 glycans shown by the rEng/195-D222N virus has been
previously address with similar results using a recombinant virus
with a D222N mutated HA (Yang et al., 2010). The rEng/195-S185N
bound to a wider range of α2,6 glycans (#331, 481, 601, 605, 55, 57,
501, 344 and 600) and showed no signiﬁcant binding to α2,3
glycans. Notably, the double mutant rEng/195-S185NþD222N
showed signiﬁcant binding to both α2,3 (#599, 606, 460) and
α2,6 glycans (#481, 479).
Interestingly, all three mutants exhibited prominent binding to
non-Neu5Ac glycans of long bi-or tri-antennary structure containing
repeated molecules of galactose (Gal) and N-acetyl-glucosamine
(GlcNac), some of them containing a fucose group (Fig. 2B–D). It is
also notable that the preference for these non-sialylated glycans is
enhanced when the mutation S185N is added to the single mutant
D222N. The structure of the top ﬁve glycans with signiﬁcant binding
for each virus is shown in Fig. 3A–D. Notably, a similar pattern of
binding has been reported for an A(H1N1)pdm09 virus isolated in a
fatal case of infection from a pediatric patient (Bradley et al., 2011),
though, based on the reported partial sequence of the HA protein, this
virus differs at amino acid 185 and 222 compared to our mutants. The
signiﬁcance of these ﬁndings is unclear.
Fig. 2. Glycan microarray analysis. Receptor binding speciﬁcity of (A) wild type and (B–D) mutant viruses. Glycans were reordered from the original format as follows: green,
α2,3 sialosides; yellow, α2,6 sialosides; pink, α2,8 sialosides; no color, sialic acid and asialo-glycans. The number of glycans on the abscissa corresponds only to glycans with
RFU values above zero. The ﬂuorescent binding signal intensity is indicated at the y axis. The red line across the graph corresponds to the background average in RFU: 2270
for rEng/195-wt; 512 for rEng/195-D222N; 569 for rEng/195-S185N; and 290 for rEng/195-S185NþD222N.
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Secondary mutation S185N modiﬁes the cell tropism of D222N virus
by increasing the infection rate in HTBE culture
Finally, we investigated the cell tropism and infection rate of
the recombinant viruses in HTBE cells. Infected HTBE sections
were stained with antiserum to detect inﬂuenza NP, and co-
stained with lectins, Maackia amurensis (MAL I) or Sambucus nigra
(SNA; Fig. 4A). The number and type of infected cells was recorded
from three different sections. Absolute numbers from cell counts
(Fig. 4B) indicate that mutants rEng/195-S185N and rEng/195-
S185NþD222N infected the highest number of cells, followed by
the rEng195-wt. Interesting, the single mutant rEng195-D222N
infected the lowest percentage of HTBE cells, three times less than
the virus containing the double mutant HA. These results are in
agreement with the data from the growth curve; it conﬁrms our
previous observation that mutation D222N affects early infection
rates within the ﬁrst 24 h post-infection, reducing the number of
infected cells.
Co-staining for viral antigen and sialic acids (Fig. 4C) revealed that
most of the cells (70%) infected by rEng/195-wt also stained for SNA,
indicating they expressed α2,6-SA. Our previous data suggests
many of these are non-ciliated cells (Ayora-Talavera et al., 2009;
Thompson et al., 2006). The single mutant rEng/195-D222N also
showed preferential infection of cells expressing α2,6-SA. However,
the single mutant rEng/195-S185N or double mutant rEng/195-
S185NþD222N infected cells co-stained for SNA or MAA equivalently,
suggesting the increase in number of cells infected wasmediated by an
ability to enter cells using either α2,6-SA or α2,3-SA receptors. Taken
together with the ﬁnding of increased replication in HTBE, these data
indicate that the single mutation S185N confers efﬁcient recognition of
both types of receptors, and that even when coupled with D222N, it
maintains the broad tropism phenotype. We suggest that the combi-
nation S185NþD222N detected in a fatal inﬂuenza infection led to
increased replication and expanded cell tropism.
The observations of heterogeneity at positions such as HA1 222
encompassing residues that convey different binding phenotypes
might reﬂect a balance between selective pressures operating on
these virus populations. Transmission efﬁciency in humans would
favor viruses with α2,6-SA speciﬁcity due to the abundance of
α2,6-SA in the upper respiratory tract of humans, and resistance to
inhibitory effects of α2,3-SA-rich respiratory mucins. However,
within infected individuals selection of α2,3-SA binding variants
could allow for attachment to alternative cell types. Enrichment of
the latter phenotype might be expected in patients displaying
more severe symptoms, including infection of the lower respira-
tory tract where α2,3-SA receptors are more prevalent.
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Fig. 3. Structure of the top highest binding glycans. Top ﬁve glycans with %CV less than 50% bound by (A) wild type and (B–D) mutant viruses. %CV was provided by glycan
array analysis software. Glycan nomenclature is as follows: purple diamond, Neu5Ac; yellow circle, Galactose; yellow square, GalNac; blue square, GlcNAc; red triangle,
fucose; OSO3, sulfate group; green circle, Mannose. Linkages are indicated between sugar symbols.
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Conclusion
We have described the receptor binding properties of an A
(H1N1)pdm09 virus containing a D222N substitution at a position
noted for polymorphisms in clinical isolates from severe or fatal
inﬂuenza. Our results suggest that viruses containing this muta-
tion alone may not contribute to the severity/fatality of the
affected patients as indicated by the loss of binding and delayed
replication in HTBE cultures.
The literature review indicates that substitution D222N is
detected as a minor population in viruses isolated from throat
and/or bronchial samples (Baldanti et al., 2011; Resende et al.,
2014; Wang et al., 2011); worldwide the D222N has been reported
in only 0.41% of viral sequences (http://www.ﬂusurver.bii.a-star.
edu.sg). In Mexico, polymorphisms 222R/G/N are found in 7.7% of
361 HA sequences; where the frequency of detection is 53% for
222R [code for A or G-AAT (N), AGT (S), GGT (G) or GAT (D)], 36%
for 222G and 11% for 222N. The clinical and epidemiological
analysis for some of these viruses has been recently described
(Vazquez-Perez et al., 2013).
The most interesting and novel ﬁnding of our study is the effect
that S185N has on the binding, replication and cell tropism of the
A(H1N1)pdm09 virus. In public databases, this mutation has been
reported only in a small proportion of viral isolates (0.34%), and to
our knowledge, this is the ﬁrst report of the effects of S185N in
conjunction with D222N.
In conclusion, in this study we have addressed the impact of
viral variants with mutations that affect virus survival at early time
during replication. These viruses evolve by acquiring compensa-
tory mutations to expand their cell tropism and, as a consequence,
increase the severity of the infection and clinical outcome of the
patient (Casalegno et al., 2014; Houng et al., 2012; Vazquez-Perez
et al., 2013).
Materials and methods
Cell lines
Madin-Darby Canine Kidney (MDCK) cells were maintained in
DMEM (Dulbecco's Modiﬁed Eagle Medium) supplemented with
10% fetal bovine serum (FBS), 1% penicillin/streptomycin (Gibco,
USA) and 1% of non essential amino acids 100x (Sigma-Aldrich,
USA). Cells were incubated at 37 1C in 5% CO2.
Human tracheobronchial epithelial (HTBE) cells were obtained
from MatTek (Massachusetts, USA) and shipped ready to use in 24
wells plate and seeded on transwell membrane of 6.5 mm of
diameter with a pore size of 0.4 μm (Corning, USA). HTBE cells
were cultured following manufacturer's protocol. Brieﬂy, HTBE
cells were grown in an air–liquid interface during 20 days to form
a differentiated, polarized culture that resemble in vivo the
pseudostratiﬁed mucociliary epithelium. AIR-100-ASY pre-
warmed media was replaced in the basal area of the culture every
72–96 h. Prior to the experiment, cells were rinsed with AIR-100-
ASY media and incubated during 30 min at 37 1C, 5% CO2 to
remove the excess mucus.
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Fig. 4. Binding and cell tropism in HTBE cultures. Lectin binding and co-staining with anti-inﬂuenza NP. The preference of binding to ciliated and non-ciliated cells by lectins
(A) MAA and (B) SNA is shown by white arrows respectively. Yellow arrows indicate cilia stained with anti-alpha tubulin. The (A) right panels show co-staining between MAA
or SNA and inﬂuenza NP protein for rEng/195-WT and each mutant. (B) The total number of infected cells (nucleus stained in red) for each virus was counted from two
different tissue sections. (C) The preference of infection and cell tropism of the WT and mutant viruses was inferred from the co-staining with SNA and MAA lectins; data are
expressed as percentage considering the absolute numbers of infected cells as the 100%.
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Viruses
Recombinant viruses were generated by reverse genetics on the
background of the viral A(H1N1)pdm09 virus A/England/195/2009
(rEng195). Viruses were rescued by a 12 plasmid transfection of 293T
and MDCK co-culture as previously described (Shelton et al., 2012).
Relevant mutations were generated by direct mutagenesis with
Quickchange Lightning Site-Directed Mutagenesis protocol (Strate-
gene, CA, USA). A total of four recombinant viruses including the WT
were rescued, viruses containing single S185N, D222N and double
mutations S185NþD222N at the RBS of the HA were identiﬁed as
rEng195-WT, rEng195-S185N, rEng195-D222N and rEng195-
S185NþD222N, respectively. The HA gene of recombinant viruses
was sequenced to detect the emergence of possible revertants and
subdominant sequence variants during ampliﬁcation.
Cell infection
MDCK cells were infected with mutant rEng195-S185N, rEng195-
D222N and rEng195-S185NþD222N and rEng195-WT viruses at
multiplicity of infection (MOI) of 0.01 PFU. After 1 h incubation at
room temperature (RT), viruses were removed and cells incubated for
72 h at 37 1C with DMEM supplemented with 2 μg/ml of TPCK-
Trypsin. Viruses were harvested every 12 h and viral titer was
obtained by standard plaque assay in MDCK cells.
HTBE cells were infected with viruses at MOI of 0.001 PFU.
After 1 h incubation at RT, viruses were removed and cells
incubated for 72 h at 37 1C with MucilAir media.
Prior to virus collection, cells were incubated for 30 min with
330 μl of media; secreted viruses were harvested at 12, 24, 48 and
72 h post-infection from the apical side of the culture. Viral titer
was obtained by plaque assay in MDCK cells.
Virus puriﬁcation and labeling
Prior to analysis on the glycan array, viruses were grown in
MDCK cells and puriﬁed by ultra-speed centrifugation through a
25% sucrose cushion in NTE buffer (100 mM Tris–HCl pH7.4,
100 mM NaCl and 1 mM EDTA). Viruses were centrifuged for 3 h
at 25,000 rpm at 4 1C, supernatant was removed and viruses were
incubated in 250–500 μL of PBS 1 overnight. Viruses were
resuspended, aliquoted and stored at 80 1C.
Viruses were labeled with the amine reactive dye Alexa
Fluor488 (Invitrogen, USA). Twenty-ﬁve micrograms of amine
reactive Alexa Fluor488 was incubated with 300 μL of virus and
30 μL of 1 M NaHCO3 (pH 9.0) for 1 h. The labeled viruses were
dialyzed overnight in a 7000 MWCO Slide-A-Lyzer MINI dialysis
unit (Thermo Scientiﬁc) against PBSþ1 mM EDTA.
Glycan arrays
The Consortium of Functional Glycomics performed glycan
microarray binding experiments (www.functionalglycomics.org)
using Core H, version V5.2. Signiﬁcant peaks were determined
by averaging the relative ﬂuorescent units (RFU) of all glycans on
the microarray, which was then multiplied by two to determine
the background RFU level. Signiﬁcant binding was considered to
be two times the background average, with a % CV of less than 50%.
Immunohistochemical analysis
Human tracheobronchial epithelial cells (HTBE) cells were
infected with mutants and WT viruses at multiplicity of infection
(MOI) of 1.0 and allowed to incubate for 16 h at 37 1C. Transwell
membranes were embedded in parafﬁn by standard tissue proces-
sing procedures, and cut at 4 μm and afﬁxed on glass slides in
collaboration with the Yerkes National Primate Research Center at
Emory University. Lectin staining was performed using biotin
labeled Sambucus nigra (SNA) and Maackia amurensis agglutinins
(MAA), purchased from Vector Laboratories (USA). The sections
were deparafﬁnized and rehydrated. Non-speciﬁc binding was
blocked using 3% bovine serum albumin (BSA) in phosphate-
buffered saline (PBS) for 16 h at 4 1C before incubation with
ligands. SNA or MAA were diluted in 1% BSA in PBS and incubated
16 h at 4 1C. After washing in PBS-T, slides were incubated with
complexed Streptavidin-FITC (Invitrogen) in 1% BSA/PBS. For co-
localization of inﬂuenza A proteins, slides were stained with
mouse anti-inﬂuenza A nucleoprotein (NP) and goat anti-mouse
IgG conjugated to Alexa Fluor 568 (Invitrogen) diluted in 1% BSA/
PBS for 1 h at 25 1C. Slides were washed and viewed under a
confocal microscope. Images were collected on a Zeiss Pascal
LSM510 laser scanning microscope using Axiovert2 imaging soft-
ware using a Plan-Apochromat 401.4 Ph3 lens. The number of
different cell types infected by each virus was quantiﬁed by
counting at least 10 different ﬁelds of two different tissue sections.
Aknowledgments
This work was supported by Consejo Nacional de Ciencia y
Tecnología Grant SEP/Conacyt-2009-131965. Confocal work was per-
formed in LANNBIO-Cinvestav Merida (CONACYT Proy Lab 123913 y
FOMIX-Yucatán Proy 108160). We thank MSc. Heredia-Cervera for the
technical assitance. LBL and DAS acknowledge support by the
U.S. Department of Health and Human Services contract
HHSN272201400004C (NIAID Centers of Excellence for Inﬂuenza
Research and Surveillance).
References
Abed, Y., Pizzorno, A., Hamelin, M.E., Leung, A., Joubert, P., Couture, C., Kobasa, D.,
Boivin, G., 2011. The 2009 pandemic H1N1 D222G hemagglutinin mutation
alters receptor speciﬁcity and increases virulence in mice but not in ferrets. J.
Infect. Dis. 204, 1008–1016.
Ayora-Talavera, G., Shelton, H., Scull, M., Ren, J., Jones, M.J., Pickles, R.J., Barclay, W.S.,
2009. Mutations in H5N1 inﬂuenza virus hemagglutinin that confer binding to
human tracheal airway epithelium. PLos One 4, e7836.
Ayora-Talavera, G., Betancourt-Cravioto, M., Gómez-Carballo, J., Conde-Ferráez, L.,
González-Losa, R., Manrique-Saide, P., Cuauhtémoc Sánchez, E., Quijano-Vivas, A.,
2012. Epidemiologic study of human inﬂ uenza A (H1N1) pdm09 virus in
Yucatan, Southern Mexico. Rev. Biomed. 23, 39–46.
Ayora-Talavera, G., Cetina-Montejo, L., Matos-Patrón, A., Romero-Beltrán, L., 2014.
Hemagglutinin variants of inﬂuenza A(H1N1)pdm09 virus with reduced afﬁnity
for sialic acid receptors. Arch. Virol. 159, 1207–1211.
Baillie, G.J., Galiano, M., Agapow, P.M., Myers, R., Chiam, R., Gall, A., Palser, A.L.,
Watson, S.J., Hedge, J., Underwood, A., Platt, S., McLean, E., Pebody, R.G.,
Rambaut, A., Green, J., Daniels, R., Pybus, O.G., Kellam, P., Zambon, M., 2012.
Evolutionary dynamics of local pandemic H1N1/2009 inﬂuenza virus lineages
revealed by whole-genome analysis. J. Virol. 86, 11–18.
Baldanti, F., Campanini, G., Piralla, A., Rovida, F., Braschi, A., Mojoli, F., Iotti, G., Belliato, M.,
Conaldi, P.G., Arcadipane, A., Pariani, E., Zanetti, A., Minoli, L., Emm, V., 2011. Severe
outcome of inﬂuenza A/H1N1/09v infection associated with 222G/N polymorph-
isms in the haemagglutinin: a multicentre study. Clin. Microbiol. Infect. 17,
1166–1169.
Bradley, K.C., Jones, C.A., Tompkins, S.M., Tripp, R.A., Russell, R.J., Gramer, M.R.,
Heimburg-Molinaro, J., Smith, D.F., Cummings, R.D., Steinhauer, D.A., 2011.
Comparison of the receptor binding properties of contemporary swine isolates
and early human pandemic H1N1 isolates (Novel 2009 H1N1). J. Virol. 413,
169–182.
Casalegno, J.S., Ferraris, O., Escuret, V., Bouscambert, M., Bergeron, C., Line’s, L.,
Excofﬁer, T., Valette, M., Frobert, E., Pillet, S., Pozzetto, B., Lina, B., Ottmann, M.,
2014. Functional balance between the hemagglutinin and neuraminidase of
inﬂuenza A(H1N1)pdm09 HA D222 variants. PLos One 9, e104009.
Chen, C., Wen, X., To, K.K.W., Wang, P., Tse, H., Chan, J.F.W., Tsoi, H.W., Fung, K.S.C.,
Tse, C.W.S., Lee, R.A., Chan, K.H., Yuen, K.Y., 2010. Quasispecies of the D225G
substitution in the hemagglutinin of pandemic inﬂuenza A(H1N1) 2009 virus
from patients with severe disease in Hong Kong, China. J. Infect. Dis. 201,
1517–1521.
Chen, LM, Rivailler, P., Hossain, J., Carney, P., Balish, A., Perry, I., Todd Davis, C., Garten, R.,
Shu, B., Xu, X., Klimov, A., Paulson, J.C., Cox, N., Swenson, S., Stevens, J., Vincent, A.,
A. Matos-Patrón et al. / Virology 484 (2015) 15–2120
Gramer, H., Donis, R.O., 2011. Receptor speciﬁcity of subtype H1 inﬂuenza A viruses
isolated from swine and humans in the United States. Virology 412, 401–410.
Chowell, G., Bertozzi, S., Coclhero, A., Lopez-Gatel, H., Alpuche-Aranda, C., Hernan-
dez, M., Miller, M.A., 2009. Severe respiratory disease concurrent with the
circulation of H1N1 inﬂuenza. N. Engl. J. Med. 361, 674–679.
Chowell, G., Echevarría-Zuno, S., Viboud, C., Simonsen, J., Tamerius, M., Miller, V.,
et al., 2011. Characterizing the epidemiology of the 2009 inﬂuenza A/H1N1
pandemic in Mexico. PLoS Med. 8, e1000436.
Chutinimitkul, S., Herfst, S., Steel, J., Lowen, A.C., Jianqiang, Y., van Riel, D., et al.,
2010. Virulence-associated substitution D222G in the hemagglutinin of 2009
pandemic inﬂuenza A(H1N1) virus affects receptor binding. J. Virol. 84,
11802–11813.
de Vries, R.P., de Vries, E., Martínez-Romero, C., McBride, R., van Kuppeveld, F.J.,
Rottier, P.J.M., García-Sastre, A., Paulson, J.C., de Hann, C.A.M., 2013. Evolution of
the hemagglutinin protein of the new pandemic H1N1 inﬂuenza virus:
maintaining optimal receptor binding by compensatory substitutions. J. Virol.
87, 13868–13877.
Drews, S.J., Pabbaraju, K., Wong, S., Tokaryk, K.L., May-Hadford, J., Lee, B., Tellier, R.,
Louie, M., 2011. Surveillance of autopsy cases for D222G substitutions in
haemagglutinin of the pandemic (H1N1) 2009 virus in Alberta, Canada. Clin.
Microbiol. Infect. 17, 582–584.
ECDC. 2013. Inﬂuenza virus characterization. Surveillance report. Summary Europe
December 2013.
El Moussi, A., Kacem, M.A.B., Pozo, F., Ledesma, J., Cuevas, M.T., Casas, I., Slim, A.,
2013. Frequency of D222G haemagglutinin mutant of pandemic (H1N1) pdm09
inﬂuenza virus in Tunisia between 2009 and 2011. Diagn. Pathol. 8, 124.
Elderﬁeld, R., Watson, S.J., Godlee, A., Adamson, W.E., Thompson, C.I., Dunning, J.,
Fernandez-Alonso, M., Blumenkrantz, D., Hussell, T., The MOSAIC investigators,
Zambon, M., Openshaw, P., Kellam, P., Barclay, W.S., 2014. Accumulation of
human-adapting mutations during circulation of A(H1N1)pdm09 inﬂuenza in
humans in the UK. J. Virol. 88, 13269–13283.
Houng, H.S.H., Garner, J., Zhou, Y., Lyons, A., Kuschner, R., Deye St, G., Clair, K.,
Douce, R.W., Chicaiza, W., Blair, P.J., Myers, C.A., Burke, R.L., Sanchez, J.L.,
Williams, M., Halsey, E.S., 2012. Emergent 2009 inﬂuenza A(H1N1) viruses
containing HA D222N mutation associated with severe clinical outcomes in the
Americas. J. Clin. Virol. 53, 12–15.
Klimov, A,G.R., Russell, C., Barr, I.G., Besselaar, T.G., Daniels, R., Engelhardt, O.G.,
Itamura, S., Kelso, A., McCauley, J., Odagiri, T., Smith, D., Tashiro, M., Xu, X.,
Webby, R., Wang, D., Ye, Z., Yuelong, S., Zhang, W., Cox, N., Writing Committee
of the World Health Organization Consultation on Southern Hemisphere
Inﬂuenza Vaccine Composition for 2012, 2012. WHO recommendations for
the viruses to be used in the 2012 southern hemisphere inﬂuenza vaccine:
epidemiology, antigenic and genetic characterization of inﬂuenza A(H1N1)
9pdm09, A(H3N2) and B inﬂuenza viruses collected from February to Septem-
ber 2011. Vaccine 30, 6461–6471.
Ledesma, J., Pozoa F., Ruiz M.P., Navarro J.M., Piñeiroc L., Montes M., Castro S.P.,
Fernández J.F., Costa J.G., Fernández M., Galáng J.C., Cuevas M.T., Casas I., Breña P.P.,
Spanish Inﬂuenza Surveillance System (SISS). 2011. Substitutions in position 222 of
haemagglutinin of pandemic inﬂuenza A (H1N1) 2009 viruses in Spain. J. Clin.
Virol. 51:75-78.
Liu, Y., Childs, R.A., Matrosovich, T., Wharton, S., Palma, A.S., Chai, W., Daniels, R.,
Gregory, V., Uhlendorf, J., Kiso, M., Klenk, H.D., Hay, A., Feizi, T., Matrosovich, M.,
2010. Altered receptor speciﬁcity and cell tropism of D225G hemagglutinin
mutants isolated from fatal cases of pandemic A(H1N1) 2009 inﬂuenza virus. J.
Virol. 84, 12069–12074.
Matrosovich, M., Matrosovich, T.Y., Gray, T., Roberts, N.A., Klenk, H.D., 2004. Human
and avian inﬂuenza viruses target different cell types in cultures of human
airway epithelium. Proc. Natl. Acad. Sci. 101, 4620–4624.
Resende, P.C., Motta, F.C., Oliveira, M.L.A., Gregianini, T.S., Fernandes, S.B., Cury, A.L.F.,
Rosa, M.C.D., Souza, M.L., Siqueira, M.M., 2014. Polymorphisms at residue 222 of
the hemagglutinin of pandemic inﬂuenza A(H1N1)pdm09: association of quasi-
species to morbidity and mortality in different risk categories. PLos One 9,
e92789.
Rykkvin, R., Kilander, A., Dudman, S.D., Hungnes, O., 2013. Within-patient emer-
gence of the inﬂuenza A(H1N1) pdm09 HA1 222G variant and clear association
with severe disease, Norway. Euro Surveill 18, 20369.
Shelton, H., Smith, M., Hartgroves, L.C.S., Stilwell, P., Roberts, K.L., Johnson, B.,
Barclay, W.S., 2012. An inﬂuenza reassortant with polymerase of pH1N1 and NS
gene of H3N2 inﬂuenza A virus is attenuated in vivo. J. Gen. Virol. 93, 998–1006.
Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., Kawaoka, Y., 2006. Inﬂuenza
virus receptors in the human airway. Nature 440, 435–436.
Thompson, C.I., Barclay, W.S., Zambon, M.C., Pickles, R.J., 2006. Infection of human
airway epithelium by human and avian strains of inﬂuenza A virus. J. Virol. 80,
8060–8068.
Van Riel, D., Munster, V.J., de Wit, E., Rimmelzwaan, G.F., Fouchier, R.A.M.,
Osterhaus, ADME, Kuiken, T., 2006. H5N1 virus attachment to lower respiratory
tract. Science 312, 399.
Vazquez-Perez, J., Isa, P., Kobasa, D., Ormsby, C.E., Ramírez-Gonzalez, J.E., Romero-
Rodríguez, D.P., Ranadheera, C., Li, Y., Bastien, N., Embury-Hyatt, C., González-
Duran, E., Barrera-Badillo, G., Ablanedo-Terrazas, Y., Sevilla-Reyes, E., Escalera-
Zamudio, M., Cobián-Güemes, A., Lopez, I., Ortiz-Alcántara, J., Alpuche-Aranda, C.,
Perez-Padilla, J., Reyes-Terán, G., 2013. A (H1N1) pdm09 HA D222 variants
associated with severity and mortality in patients during a second wave in
Mexico. Virol. J. 10, 41.
Wang, B., Dwyer, D.E., Soedjono, M., Shi, H., Matlho, K., Ratnamohan, M., Blyth, C.,
McPhie, K., Cunningham, A.L., Saksena, N.K., 2011. Evidence of the circulation of
pandemic inﬂuenza (H1N1) 2009 with D222D/G/N/S hemagglutinin poly-
morphisms during the ﬁrst wave of the 2009 inﬂuenza pandemic. J. Clin. Virol.
52, 304–306.
Xu, R., Ekiert, D.C., Krause, J.C., Hai, R., Crowe Jr, J.E., Wilson, I.A., 2010. Structural
basis of preexisting immunity to the 2009 H1N1 pandemic inﬂuenza virus.
Science 328, 357–360.
Yang, H., Carney, P., Stevens, J., 2010. Structure and Receptor binding properties of a
pandemic H1N1 virus hemagglutinin. PLOS Currents Inﬂuenza, http://dx.doi.
org/10.1371/currents.RRN1152.
A. Matos-Patrón et al. / Virology 484 (2015) 15–21 21
